SONOSCAPE(SZ:300633) Zheng Quan Zhi Xing·2025-09-05 12:19Summary of Key Points Core Viewpoint - Shenzhen Kaili Biomedical Technology Co., Ltd. has proposed an incentive plan involving the allocation of restricted stocks and stock options to its middle management and technical personnel, aiming to enhance employee motivation and align their interests with the company's growth [1]. Group 1: Restricted Stock Allocation - The plan proposes to grant a total of 191.4 million shares of restricted stock, with 179.4 million shares (93.73%) allocated to middle management and technical personnel [1]. - The total number of shares granted does not exceed 1% of the company's total share capital, and the cumulative number of shares involved in all effective incentive plans will not exceed 20% of the company's total share capital at the time of submission for shareholder approval [1]. Group 2: Stock Option Allocation - The plan also includes the allocation of 396.78 million stock options, with all options (100%) designated for middle management and technical personnel [1]. - Similar to the restricted stock, the total number of stock options granted does not exceed 1% of the company's total share capital, and the cumulative number of shares involved in all effective incentive plans will not exceed 20% of the company's total share capital at the time of submission for shareholder approval [1].